Kreon 25000

Pancreatin, the active ingredient in Kreon 25000, is a pancreatic enzyme presented as a high‑potency oral capsule for oral use. It provides exogenous lipases, proteases and amylases to aid digestion in patients with exocrine pancreatic insufficiency.

GNH USA supplies Kreon 25000 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Kreon 25000 is used to replace deficient pancreatic enzymes in conditions characterized by exocrine pancreatic insufficiency. - Cystic fibrosis: improves digestion of fats, proteins and carbohydrates, reducing steatorrhea. - Chronic pancreatitis: assists nutrient absorption and alleviates malabsorption symptoms. - Pancreatic cancer: supports digestive function when the pancreas is compromised. - Post‑pancreatectomy: provides necessary enzymes for normal digestion after surgical removal of the pancreas.

Adverse reactions to Kreon 25000 are generally related to its enzymatic activity or excipients.

Common Side Effects: - Abdominal discomfort: mild pain or cramping after meals. - Flatulence: increased intestinal gas production. - Diarrhea: loose stools due to rapid fat digestion. - Nausea: feeling of sickness, especially when taken without food. - Constipation: reduced bowel movements in some patients.

Serious or Rare Side Effects: - Pancreatitis: inflammation of the pancreas. - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Severe abdominal pain: may indicate serious gastrointestinal complication.

Before prescribing Kreon 25000, clinicians should consider several safety and handling precautions. - Assess pancreatic function: confirm exocrine insufficiency before use. - Adjust dose with meals: take with each main meal and snack for optimal effect. - Monitor for allergic response: discontinue if rash or swelling develops. - Use caution in patients with gastrointestinal disorders: may exacerbate symptoms. - Review concomitant medications: certain acid‑reducing agents can affect enzyme activity. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture.

Kreon 25000 may interact with other medicines that affect gastric acidity or enzyme activity.

Major Interactions (Avoid): - Proton pump inhibitors: reduce gastric acidity, potentially decreasing enzyme activation. - H2‑receptor antagonists: similar effect on enzyme efficacy.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: may bind enzymes and lower effectiveness. - Oral contraceptives: theoretical reduction in absorption, monitor clinical response. - Lipid‑lowering agents (e.g., orlistat): concurrent use may interfere with fat digestion and enzyme activity.